C
Cameron Fraser
Researcher at Harvard University
Publications - 21
Citations - 589
Cameron Fraser is an academic researcher from Harvard University. The author has contributed to research in topics: Apoptosis & Medicine. The author has an hindex of 6, co-authored 10 publications receiving 440 citations.
Papers
More filters
Journal ArticleDOI
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
Jan A. Burger,Dan A. Landau,Amaro Taylor-Weiner,Ivana Bozic,Huidan Zhang,Huidan Zhang,Huidan Zhang,Kristopher A. Sarosiek,Lili Wang,Chip Stewart,Jean Fan,Julia Hoellenriegel,Mariela Sivina,Adrian M. Dubuc,Cameron Fraser,Yu Long Han,Shuqiang Li,Kenneth J. Livak,Lihua Zou,Youzhong Wan,Sergej Konoplev,Carrie Sougnez,Jennifer R. Brown,Lynne V. Abruzzo,Scott L. Carter,Michael J. Keating,Matthew S. Davids,William G. Wierda,Kristian Cibulskis,Thorsten Zenz,Lillian Werner,Paola Dal Cin,Peter Kharchencko,Donna Neuberg,Hagop M. Kantarjian,Eric S. Lander,Stacey Gabriel,Susan O'Brien,Anthony Letai,David A. Weitz,Martin A. Nowak,Gad Getz,Catherine J. Wu,Catherine J. Wu,Catherine J. Wu +44 more
TL;DR: It is demonstrated that the ibrutinib therapy favours selection and expansion of rare subclones already present before ibrUTinib treatment, and insight is provided into the heterogeneity of genetic changes associated with ibrutsinib resistance.
Journal ArticleDOI
Developmental Regulation of Mitochondrial Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics.
Kristopher A. Sarosiek,Cameron Fraser,Nathiya Muthalagu,Patrick Bhola,Wei-Ting Chang,Wei-Ting Chang,Samuel K. McBrayer,Adam Cantlon,Adam Cantlon,Sudeshna Fisch,Sudeshna Fisch,Gail Golomb-Mello,Jeremy Ryan,Jing Deng,Brian Jian,Chris Corbett,Marti Goldenberg,Joseph R. Madsen,Joseph R. Madsen,Ronglih Liao,Ronglih Liao,Dominic M. Walsh,Dominic M. Walsh,John M. Sedivy,Daniel J. Murphy,Daniel R. Carrasco,Shenandoah Robinson,Shenandoah Robinson,Javid Moslehi,Anthony Letai +29 more
TL;DR: Using BH3 profiling, it is found that mitochondria of many adult somatic tissues, including brain, heart, and kidneys, are profoundly refractory to pro-apoptotic signaling, leading to cellular resistance to cytotoxic chemotherapies and ionizing radiation.
Journal ArticleDOI
Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in KRAS-Mutant Non-Small Cell Lung Cancer.
Varuna Nangia,Faria M. Siddiqui,Sean Caenepeel,Daria Timonina,Samantha J. Bilton,Nicole Phan,Maria Gomez-Caraballo,Hannah L. Archibald,Chendi Li,Cameron Fraser,Diamanda Rigas,Kristof Vajda,Lorin A. Ferris,Michael Lanuti,Cameron D. Wright,Kevin A. Raskin,Daniel P. Cahill,John H. Shin,Colleen Keyes,Lecia V. Sequist,Zofia Piotrowska,Anna F. Farago,Christopher G. Azzoli,Justin F. Gainor,Kristopher A. Sarosiek,Sean P. Brown,Angela Coxon,Cyril H. Benes,Paul E. Hughes,Aaron N. Hata +29 more
TL;DR: It is demonstrated that concurrent MEK + MCL1 inhibition induces apoptosis and tumor regression in KRAS-mutant non-small cell lung cancer (NSCLC) models, which respond poorly to MEK inhibition alone.
Journal ArticleDOI
Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 severity.
Zintis Inde,Ben A. Croker,Clarence Yapp,Gaurav N. Joshi,Gaurav N. Joshi,Johan Spetz,Cameron Fraser,Xingping Qin,Le Xu,Brian Deskin,Elisa Ghelfi,Gabrielle Webb,Aaron F. Carlin,Yanfang Peipei Zhu,Sandra L Leibel,Sandra L Leibel,Aaron F. Garretson,Alex E. Clark,Jason M. Duran,Victor Pretorius,Laura E. Crotty-Alexander,Chendi Li,Jamie Casey Lee,Chhinder P. Sodhi,David J. Hackam,Xin Sun,Aaron N. Hata,Lester Kobzik,Jeffrey W. Miller,Jin-Ah Park,Douglas Brownfield,Hongpeng Jia,Kristopher A. Sarosiek +32 more
TL;DR: In this article, the authors found that mRNA and protein expression of angiotensin-converting enzyme 2 (ACE2), the cell entry receptor for the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), increases with advancing age in distal lung epithelial cells.
Journal ArticleDOI
Mechanisms of lymphoma clearance induced by high-dose alkylating agents
Chen Lossos,Yunpeng Liu,Yunpeng Liu,Kellie E. Kolb,Kellie E. Kolb,Kellie E. Kolb,Amanda L. Christie,Alexandria Van Scoyk,Sanjay M. Prakadan,Sanjay M. Prakadan,Sanjay M. Prakadan,Kay Shigemori,Kristen E. Stevenson,Sara N. Morrow,Olivia Plana,Cameron Fraser,Kristen L Jones,Huiyun Liu,Christian P. Pallasch,Rebecca Modiste,Quang-Dé Nguyen,Jeffrey W. Craig,Elizabeth A. Morgan,Francisco Vega,Jon C. Aster,Kristopher A. Sarosiek,Alex K. Shalek,Alex K. Shalek,Alex K. Shalek,Michael T. Hemann,Michael T. Hemann,David M. Weinstock +31 more
TL;DR: It is shown that antibody resistance within the bone marrow (BM) is not present upon early engraftment but develops during lymphoma progression, and a novel mechanism through which high-dose alkylating agents promote macrophage-dependent lymphoma clearance is defined.